Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants

af Goette, Andreas, Vranckx, Pascal
Udgivet i Eur Heart J Suppl (2020)

The Significance of Drug—Drug and Drug—Food Interactions of Oral Anticoagulation

af Vranckx, Pascal, Valgimigli, Marco, Heidbuchel, Hein
Udgivet i Arrhythm Electrophysiol Rev (2018)

Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help

af Gargiulo, Giuseppe, Goette, Andreas, Vranckx, Pascal, Valgimigli, Marco
Udgivet i Eur Heart J (2020)

SPOT the DIAGNOSIS

af Verbrugge, Frederik H, Morrow, David A, Vranckx, Pascal
Udgivet i Eur Heart J Acute Cardiovasc Care (2021)

Physical manoeuvers as a preventive intervention to manage vasovagal syncope: A systematic review

af Dockx, Kim, Avau, Bert, De Buck, Emmy, Vranckx, Pascal, Vandekerckhove, Philippe
Udgivet i PLoS One (2019)

Respiratory management in severe acute respiratory syndrome coronavirus 2 infection

af Price, Susanna, Singh, Suveer, Ledot, Stephane, Bianchi, Paolo, Hind, Matthew, Tavazzi, Guido, Vranckx, Pascal
Udgivet i Eur Heart J Acute Cardiovasc Care (2020)

The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?

af Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Lopes, Renato D, Vranckx, Pascal, Valgimigli, Marco
Udgivet i Eur Heart J Cardiovasc Pharmacother (2020)

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis

af Goette, Andreas, Eckardt, Lars, Valgimigli, Marco, Lewalter, Thorsten, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan G., Vranckx, Pascal
Udgivet i Clin Res Cardiol (2020)

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interve...

af Capodanno, Davide, Di Maio, Marco, Greco, Antonio, Bhatt, Deepak L., Gibson, C. Michael, Goette, Andreas, Lopes, Renato D., Mehran, Roxana, Vranckx, Pascal, Angiolillo, Dominick J.
Udgivet i J Am Heart Assoc (2020)

Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary interv...

af Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Goette, Andreas, Lopes, Renato D, Oldgren, Jonas, Korjian, Serge, Windecker, Stephan, Esposito, Giovanni, Vranckx, Pascal, Valgimigli, Marco
Udgivet i Eur Heart J Cardiovasc Pharmacother (2020)

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI...

af Vranckx, Pascal, Valgimigli, Marco, Eckardt, Lars, Lewalter, Thorsten, Unikas, Ramunas, Marin, Francisco, Schiele, François, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan, Goette, Andreas
Udgivet i Eur Heart J (2020)

STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme

af Claeys, Marc J, Sinnaeve, Peter R, Convens, Carl, Dubois, Philippe, Boland, Jean, Vranckx, Pascal, Gevaert, Sofie, de Meester, Antoine, Coussement, Patrick, De Raedt, Herbert, Beauloye, Christophe, Renard, Marc, Vrints, Christiaan, Evrard, Patrick
Udgivet 2012

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial

af Gargiulo, Giuseppe, Esposito, Giovanni, Avvedimento, Marisa, Nagler, Michael, Minuz, Pietro, Campo, Gianluca, Gragnano, Felice, Manavifar, Negar, Piccolo, Raffaele, Tebaldi, Matteo, Cirillo, Plinio, Hunziker, Lukas, Vranckx, Pascal, Leonardi, Sergio, Heg, Dik, Windecker, Stephan, Valgimigli, Marco
Udgivet i Circulation (2020)

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis

af Lopes, Renato D., Hong, Hwanhee, Harskamp, Ralf E., Bhatt, Deepak L., Mehran, Roxana, Cannon, Christopher P., Granger, Christopher B., Verheugt, Freek W. A., Li, Jianghao, ten Berg, Jurriën M., Sarafoff, Nikolaus, Vranckx, Pascal, Goette, Andreas, Gibson, C. Michael, Alexander, John H.
Udgivet i JAMA Cardiol (2020)

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

af Chieffo, Alaide, Dudek, Dariusz, Hassager, Christian, Combes, Alain, Gramegna, Mario, Halvorsen, Sigrun, Huber, Kurt, Kunadian, Vijay, Maly, Jiri, Møller, Jacob Eifer, Pappalardo, Federico, Tarantini, Giuseppe, Tavazzi, Guido, Thiele, Holger, Vandenbriele, Christophe, van Mieghem, Nicolas, Vranckx, Pascal, Werner, Nikos, Price, Susanna
Udgivet i Eur Heart J Acute Cardiovasc Care (2021)

Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease: The X-PLORER trial

af Vranckx, Pascal, Leebeek, Frank W. G., Tijssen, Jan G. P., Koolen, Jacques, Stammen, Francis, Herman, Jean-Paul R., de Winter, Robbert J., van t Hof, Arnout W. J., Backx, Bianca, Lindeboom, Wietze, Kim, So-Young, Kirsch, Bodo, van Eickels, Martin, Misselwitz, Frank, Verheugt, Freek W. A.
Udgivet i Thromb Haemost (2015)

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

af Gao, Chao, Tomaniak, Mariusz, Takahashi, Kuniaki, Kawashima, Hideyuki, Wang, Rutao, Hara, Hironori, Ono, Masafumi, Montalescot, Gilles, Garg, Scot, Haude, Michael, Slagboom, Ton, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, van Geuns, Robert-Jan, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Angiolillo, Dominick J., Serruys, Patrick W.
Udgivet i Cardiovasc Diabetol (2020)

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

af Tomaniak, Mariusz, Chichareon, Ply, Onuma, Yoshinobu, Deliargyris, Efthymios N., Takahashi, Kuniaki, Kogame, Norihiro, Modolo, Rodrigo, Chang, Chun Ching, Rademaker-Havinga, Tessa, Storey, Robert F., Dangas, George D., Bhatt, Deepak L., Angiolillo, Dominick J., Hamm, Christian, Valgimigli, Marco, Windecker, Stephan, Steg, Philippe Gabriel, Vranckx, Pascal, Serruys, Patrick W.
Udgivet i JAMA Cardiol (2019)

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium(†)

af Leon, Martin B., Piazza, Nicolo, Nikolsky, Eugenia, Blackstone, Eugene H., Cutlip, Donald E., Kappetein, Arie Pieter, Krucoff, Mitchell W., Mack, Michael, Mehran, Roxana, Miller, Craig, Morel, Marie-angèle, Petersen, John, Popma, Jeffrey J., Takkenberg, Johanna J.M., Vahanian, Alec, van Es, Gerrit-Anne, Vranckx, Pascal, Webb, John G., Windecker, Stephan, Serruys, Patrick W.
Udgivet 2011

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary art...

af Leonardi, Sergio, Franzone, Anna, Piccolo, Raffaele, McFadden, Eugene, Vranckx, Pascal, Serruys, Patrick, Benit, Edouard, Liebetrau, Christoph, Janssens, Luc, Ferrario, Maurizio, Zurakowski, Aleksander, van Geuns, Robert-Jan, Dominici, Marcello, Huber, Kurt, Slagboom, Ton, Buszman, Paweł, Bolognese, Leonardo, Tumscitz, Carlo, Bryniarski, Krzysztof, Aminian, Adel, Vrolix, Mathias, Petrov, Ivo, Garg, Scot, Naber, Christoph, Prokopczuk, Janusz, Hamm, Christian, Steg, Gabriel, Heg, Dik, Juni, Peter, Windecker, Stephan, Valgimigli, Marco
Udgivet i BMJ Open (2019)